Therapy Areas: Devices
Intrinsic Therapeutics' Barricaid Annular Closure receives ISASS updated 2025 recommendations and coverage criteria
20 June 2025 - Intrinsic Therapeutics, a US-based medical technology company involved in improving standard of care for lumbar discectomy patients with large annular defects with its Barricaid Annular...
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
20 June 2025 - Immuno Cure BioTech, a clinical-stage biotechnology group based in Hong Kong Science Park, announced on Thursday its upcoming collaboration with US-based PharmaJet to evaluate the safet...
GRAIL reports positive results from Galleri multi-cancer early detection test registrational study
19 June 2025 - GRAIL Inc (Nasdaq: GRAL), a California-based healthcare company focused on early detection of cancer, on Wednesday reported positive top-line performance and safety results from the pre...
InspireMD secures CE Mark approval for CGuard Prime EPS under European MDR
13 June 2025 -

Medical device company InspireMD, Inc. (NASDAQ:NSPR) announced on Friday that it has received CE Mark certification under the Europ...

Crossject advances paediatric development of ZEPIZURE Junior for epilepsy crisis management
11 June 2025 - Pharmaceutical company Crossject (Euronext Growth Paris:ALCJ) on Wednesday announced progress in the development of ZEPIZURE Junior, its needle-free emergency treatment for paediatric e...
Creo Medical secures FDA clearance for SpydrBlade Flex in US market
11 June 2025 - Medical device company Creo Medical Group plc (AIM: CREO) announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration for its SpydrBlade Flex device...